News | December 13, 2025
Merck wins key EU backing to expand use of PAH Drug WINREVAIR
WINREVAIR is currently the first and only activin signalling inhibitor approved for PAH across all 27 EU member states
WINREVAIR is currently the first and only activin signalling inhibitor approved for PAH across all 27 EU member states
This is the first approval of a prescription transdermal dosage Form in the European markets from this facility
The study met its primary endpoint and all 11 secondary efficacy endpoints
MRI is particularly valuable in pediatric care due to its non-invasive nature
Senores Pharmaceuticals is poised to accelerate its presence in the Asia-Pacific region
AVT03 is a biosimilar of Amgen's Prolia (denosumab 60 mg/mL) and Xgeva (denosumab 70 mg/mL), which are used to treat various bone conditions
Winlevi is authorized in EU for the treatment of acne vulgaris
FDA closes inspection at Zydus' oncology injectable manufacturing facility in SEZ1, Ahmedabad with 2 observations
This is the first drug to receive a recommendation for this preventative indication in the European Union
Exemestane is a key therapeutic used in the treatment of certain types of breast cancer in postmenopausal women
Subscribe To Our Newsletter & Stay Updated
